Pacheco-Silva A - Search Results

1

Heme oxygenase 1 and renal ischemia and reperfusion injury: the impact of immunosuppressive drug.

Gonçalves GM, Cenedeze MA, Feitoza CQ, de Paula CB, Macusso GD, Pinheiro HS, Teixeira Vde P, dos Reis MA, Pacheco-Silva A, Câmara NO. Gonçalves GM, et al. Int Immunopharmacol. 2006 Dec 20;6(13-14):1966-72. Int Immunopharmacol. 2006. PMID: 17219692

2

Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression.

Câmara NO, Nishida S, Silva MS, Pestana JO, Pereira AB, Sesso R, Pacheco-Silva A. Câmara NO, et al. Transplant Proc. 1998 Dec;30(8):4158-9. doi: 10.1016/s0041-1345(98)01378-5. Transplant Proc. 1998. PMID: 9865333 No abstract available.

3

Early detection of heart transplant patients with increased risk of ciclosporin nephrotoxicity.

Câmara NO, Matos AC, Rodrigues DA, Pereira AB, Pacheco-Silva A. Câmara NO, et al. Lancet. 2001 Mar 17;357(9259):856-7. doi: 10.1016/S0140-6736(00)04207-0. Lancet. 2001. PMID: 11265958

4

Urinary retinol binding protein is a good marker of progressive cyclosporine nephrotoxicity after heart transplant.

Camara NO, Matos AC, Rodrigues DA, Pereira AB, Pacheco-Silva A. Camara NO, et al. Transplant Proc. 2001 May;33(3):2129-31. doi: 10.1016/s0041-1345(01)01971-6. Transplant Proc. 2001. PMID: 11377474 No abstract available.

5

Adverse effects of pregnancy on renal allograft function.

Miranda CT, Melaragno C, Camara NO, Pacheco-Silva A, Medina-Pestana PJ. Miranda CT, et al. Transplant Proc. 2002 Mar;34(2):506-7. doi: 10.1016/s0041-1345(02)02612-x. Transplant Proc. 2002. PMID: 12009607 No abstract available.

6

Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury.

Feitoza CQ, Sanders H, Cenedeze M, Câmara NO, Pacheco-Silva A. Feitoza CQ, et al. Transplant Proc. 2002 Nov;34(7):2979-80. doi: 10.1016/s0041-1345(02)03507-8. Transplant Proc. 2002. PMID: 12431676 No abstract available.

7

Modulation of peripheral blood T-lymphocytes in kidney transplant recipients treated with low dose OKT3 therapy.

Galante NZ, Câmara NO, Kallás EG, Salomão R, Pacheco-Silva A. Galante NZ, et al. Immunol Lett. 2004 Jan 30;91(1):75-7. doi: 10.1016/j.imlet.2003.10.008. Immunol Lett. 2004. PMID: 14757373

8

Frequency of Valpha24+Vbeta11+ NKT cells in peripheral blood of human kidney transplantation recipients.

Galante NZ, Ozaki KS, Cenedeze MA, Kallás EG, Salomão R, Pacheco-Silva A, Câmara NO. Galante NZ, et al. Int Immunopharmacol. 2005 Jan;5(1):53-8. doi: 10.1016/j.intimp.2004.09.013. Int Immunopharmacol. 2005. PMID: 15589459

9

Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury.

Feitoza CQ, Câmara NO, Pinheiro HS, Gonçalves GM, Cenedeze MA, Pacheco-Silva A, Santos OF. Feitoza CQ, et al. Int Immunopharmacol. 2005 Jan;5(1):79-84. doi: 10.1016/j.intimp.2004.09.024. Int Immunopharmacol. 2005. PMID: 15589463

10

Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients.

Ozaki KS, Câmara NO, Galante NZ, Camargo LF, Pacheco-Silva A. Ozaki KS, et al. Int Immunopharmacol. 2005 Jan;5(1):103-6. doi: 10.1016/j.intimp.2004.09.008. Int Immunopharmacol. 2005. PMID: 15589467 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters